You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CpG

Showing 1 - 25 of 578
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pain, Dementia Trial (Pain-CPG-EIT, Pain-CPG-Education Only)

Not yet recruiting
  • Pain
  • Dementia
  • Pain-CPG-EIT
  • Pain-CPG-Education Only
  • (no location specified)
May 12, 2023

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • (no location specified)
Jan 3, 2023

Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Not yet recruiting
  • Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
    • (no location specified)
    Aug 23, 2023

    Healthcare Worker, Hepatitis B Vaccine, Nonresponder Trial in Madison (Recombinant hepatitis B vaccine with CpG adjuvant)

    Recruiting
    • Healthcare Worker, Hepatitis B Vaccine, Nonresponder
    • Recombinant hepatitis B vaccine with CpG adjuvant
    • Madison, Wisconsin
      University of Wisconsin
    Jul 5, 2022

    Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

    Not yet recruiting
    • Liver Metastasis Colon Cancer
    • IRE plus checkpoint inhibitor
    • IRE plus Checkpoint Inhibitor plus CpG-ODN
    • (no location specified)
    Sep 13, 2023

    Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)

    Completed
    Has Results
    • Cancer
    • Neoplasm
    • NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
    • Frankfurt, Germany
      Krankenhaus Nordwest
    Oct 3, 2022

    Plague, Pneumonic, Plague, Vaccine-Preventable Diseases Trial in United States (rF1V vaccine and CpG 1018® adjuvant, rF1V

    Recruiting
    • Plague, Pneumonic
    • +2 more
    • rF1V vaccine and CpG 1018® adjuvant
    • rF1V vaccine
    • Huntsville, Alabama
    • +4 more
    Aug 16, 2022

    Effectiveness of Standard Therapy of Acne Vulgaris

    Completed
    • Acne Vulgaris
      • Jakarta Pusat, Jakarta, Indonesia
        dr.Cipto Mangunkusumo National Central General Hospital
      Aug 7, 2023

      Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

      Recruiting
      • Myeloid Malignancies
      • Lymphoid Malignancies
      • NK Cell enriched-DLI only
      • NK-DLI + DUK-CPG-001
      • Durham, North Carolina
        Duke University Health System
      Mar 8, 2022

      COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

      Active, not recruiting
      • COVID-19
      • SARS-CoV-2 protein subunit recombinant vaccine
      • SARS-CoV-2 inactivated vaccine
      • Semarang, Central Java, Indonesia
      • +1 more
      Aug 8, 2022

      COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)

      Terminated
      • COVID-19
      • CpG 1018/Alum-adjuvanted SCB-2019 vaccine
      • +2 more
      • Kyiv, Ukraine
      • +3 more
      May 19, 2022

      Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

      Recruiting
      • Pancreatic Cancer
      • Metastatic Pancreatic Cancer
      • Irreversible Electroporation (IRE)
      • +2 more
      • Amsterdam, North-Holland, Netherlands
        Amsterdam University Medical Centre (location VUmc)
      Dec 18, 2022

      SARS-CoV-2 Infection Trial in Australia (ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001))

      Recruiting
      • SARS-CoV-2 Infection
      • ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001)
      • Kanwal, New South Wales, Australia
      • +5 more
      Nov 16, 2022

      Malignant Melanoma Trial in Brussels (MAGE-3.A1 peptide and CpG 7909)

      Terminated
      Has Results
      • Malignant Melanoma
      • MAGE-3.A1 peptide and CpG 7909
      • Brussels, Belgium
      • +1 more
      Aug 2, 2021

      Tumors Trial in New York (NY-ESO-1 Protein Vaccine)

      Completed
      Has Results
      • Tumors
      • NY-ESO-1 Protein Vaccine
      • New York, New York
      • +1 more
      Nov 29, 2021

      Lung Cancer, Hepatocellular Carcinoma, Solid Tumor Trial in Guangzhou (CpG-ODN)

      Recruiting
      • Lung Cancer
      • +2 more
      • CpG-ODN
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Jun 27, 2021

      Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))

      Recruiting
      • Primary Central Nervous System Lymphoma
      • Paris, France
        Hôpital Pitié-Salpêtrière
      Oct 24, 2022

      COVID-19 Trial in Adelaide (Advax-CpG55.2 adjuvanted recombinant spike protein)

      Recruiting
      • COVID-19
      • Advax-CpG55.2 adjuvanted recombinant spike protein
      • Adelaide, South Australia, Australia
        ARASMI
      Aug 15, 2022

      Epigenetics in Lupus Nephritis

      Recruiting
      • Systemic Lupus Erythematosus
      • Lupus Nephritis
      • Blood sampling
      • Göttingen, Lower Saxony, Germany
        University Medical Center Göttingen
      Feb 24, 2022

      Influenza, Influenza Immunisation Trial in United States (AF03, Delta Inulin-CpG55.2, Influenza Virus Quadrivalent Inactivated

      Completed
      Has Results
      • Influenza
      • Influenza Immunisation
      • Atlanta, Georgia
      • +7 more
      Dec 2, 2021

      COVID-19 Trial in Barranquilla, Cali (Candidate vaccine, SCB-2019)

      Not yet recruiting
      • COVID-19
      • Candidate vaccine, SCB-2019
      • Barranquilla, Colombia
      • +1 more
      Aug 23, 2022

      Prostate Cancer Trial in Frankfurt, Zurich (NY-ESO-1 protein/CpG 7909)

      Completed
      Has Results
      • Prostate Cancer
      • NY-ESO-1 protein/CpG 7909
      • Frankfurt, Germany
      • +1 more
      Jan 7, 2021

      COVID-19 Trial in Bloemfontein, Pretoria, Soweto (Candidate vaccine, SCB-2020S, Candidate vaccine, SCB-2019, Squalene based

      Active, not recruiting
      • COVID-19
      • Candidate vaccine, SCB-2020S
      • +3 more
      • Bloemfontein, South Africa
      • +2 more
      Oct 18, 2022

      Knee Osteoarthritis Trial in San Antonio, Tacoma (DoD/VA CPG Core Set + PT, DoD/VA CPG Core Set)

      Recruiting
      • Knee Osteoarthritis
      • DoD/VA CPG Core Set + PT
      • DoD/VA CPG Core Set
      • San Antonio, Texas
      • +2 more
      Oct 4, 2021

      Covid19 Trial in Canada, United States (Low Dose of KBP-COVID-19, High Dose of KBP-COVID-19, Placebo)

      Active, not recruiting
      • Covid19
      • Low Dose of KBP-COVID-19
      • +2 more
      • West Palm Beach, Florida
      • +7 more
      Aug 15, 2022